{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T20:20:28Z","timestamp":1788985228172,"version":"build-2803163510"},"reference-count":139,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,5,1]],"date-time":"2010-05-01T00:00:00Z","timestamp":1272672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2010,5]]},"DOI":"10.1002\/jps.21987","type":"journal-article","created":{"date-parts":[[2009,11,5]],"date-time":"2009-11-05T22:19:14Z","timestamp":1257459554000},"page":"2219-2239","source":"Crossref","is-referenced-by-count":115,"title":["A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases"],"prefix":"10.1016","volume":"99","author":[{"given":"Yahya E.","family":"Choonara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viness","family":"Pillay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Danckwerts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor R.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa C.","family":"du Toit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1002\/jps.21987_bb0010","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.addr.2006.07.026","article-title":"Intraocular implants for extended drug delivery: Therapeutic applications","volume":"58","author":"Bourges","year":"2006","journal-title":"Adv Drug Deliv Revs"},{"key":"10.1002\/jps.21987_bb0015","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bjo.83.11.1225","article-title":"New developments in sustained release drug delivery for the treatment of intraocular disease","volume":"83","author":"Velez","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0020","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1001\/archopht.1976.03910040006002","article-title":"The blood\u2010ocular barriers under osmotic stress: Studies on the freeze\u2010dried eye","volume":"94","author":"Laties","year":"1976","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0025","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1007049806660","article-title":"Osmotic opening of the blood\u2010brain barrier: Principles, mechanism, and therapeutic applications","volume":"20","author":"Rapoport","year":"2000","journal-title":"Cell Mol Niurobiol"},{"key":"10.1002\/jps.21987_bb0030","first-page":"341","article-title":"Vitreal, retinal, and pigment epithelial contributions to the posterior blood\u2010ocular barrier","volume":"100","author":"Foulds","year":"1980","journal-title":"Trans Ophthalmol Soc UK"},{"key":"10.1002\/jps.21987_bb0035","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0039-6257(79)90158-9","article-title":"The blood\u2010ocular barriers","volume":"23","author":"Cunha\u2010Vaz","year":"1979","journal-title":"Surv Ophthalmol"},{"key":"10.1002\/jps.21987_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02569055","article-title":"The blood\u2010ocular barriers: Past, present, and future","volume":"93","author":"Cunha\u2010Vaz","year":"1997","journal-title":"Doc Ophthalmol"},{"key":"10.1002\/jps.21987_bb0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0378-5173(86)90024-4","article-title":"Selective intraocular delivery of liposome encapsulated insulin via the non\u2010corneal absorption route","volume":"34","author":"Ahmed","year":"1986","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0050","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1002\/jps.2600721108","article-title":"Corneal penetration behavior of fl\u2010blocking agents I: Physicochemical factors","volume":"72","author":"Schoenwald","year":"1983","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0055","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/jps.2600660905","article-title":"Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine","volume":"66","author":"Sieg","year":"1977","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0060","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0378-5173(92)90309-P","article-title":"The effect of polyethylene glycol molecular weight on corneal transport and the related influence of penetration enhancers","volume":"88","author":"Liaw","year":"1992","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0065","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1023\/A:1015802427428","article-title":"The transport barrier of epithelia: A comparative study on membrane permeability and charge selectivity in the rabbit","volume":"9","author":"Rojanasakul","year":"1992","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21987_bb0070","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/jps.2600670614","article-title":"Relationship between steroid permeability across excised rabbit cornea and octanol\u2010water partition coefficients","volume":"67","author":"Schoenwald","year":"1978","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0075","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/jop.1987.3.159","article-title":"Nasal and conjunctival contributions to the systemic absorption of topical timolol in the pigmented rabbits: Implications in the design of strategies to maximize the ratio of ocular to systemic absorption","volume":"3","author":"Chang","year":"1987","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0080","first-page":"2581","article-title":"pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors","volume":"34","author":"Brechu","year":"1993","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0085","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/jps.2600770104","article-title":"Mechanisms of corneal drug penetration II: Ultra\u2010structural analysis of potential pathways for drug movement","volume":"77","author":"Grass","year":"1988","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0090","first-page":"684","article-title":"Paracellular permeability of corneal and conjunctival epithelia","volume":"30","author":"Huang","year":"1989","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0095","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/02713688509025154","article-title":"Ocular pharmacology of sulfonamides: The cornea as barrier and depot","volume":"4","author":"Maren","year":"1985","journal-title":"Curr Eye Res"},{"key":"10.1002\/jps.21987_bb0100","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1023\/A:1018938310628","article-title":"Controlled ocular timolol delivery: Systemic absorption and intraocular pressure effects in humans","volume":"11","author":"Urtti","year":"1994","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21987_bb0105","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/S0161-6420(91)32265-6","article-title":"Use of bioerodible polymers impregnated with mitomycin in glaucoma filtration surgery in rabbits","volume":"98","author":"Charles","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1002\/jps.21987_bb0110","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0014-4835(88)80093-9","article-title":"Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol","volume":"46","author":"Chang","year":"1988","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.21987_bb0115","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1089\/108076801753162807","article-title":"Review: Practical issues in intravitreal drug delivery","volume":"17","author":"Maurice","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1002\/jps.21987_bb0120","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0169-409X(94)90044-2","article-title":"Drug design strategies for ocular therapeutics","volume":"14","author":"Visor","year":"1994","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.21987_bb0125","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0169-409X(95)00012-V","article-title":"Ocular drug delivery conventional ocular formulations","volume":"16","author":"Lang","year":"1995","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.21987_bb0130","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2010recent advances","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog Retinal Eye Res"},{"key":"10.1002\/jps.21987_bb0135","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0042-6989(93)90181-U","article-title":"Dendritic architecture of on\u2010off direction\u2010selective ganglion cells in the rabbit retina","volume":"33","author":"Oyster","year":"1993","journal-title":"Vis Res"},{"key":"10.1002\/jps.21987_bb0140","first-page":"30","article-title":"Multiple modes of drug delivery","volume":"3","author":"Mort","year":"2000","journal-title":"Mod Drug Discov"},{"key":"10.1002\/jps.21987_bb0145","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0169-409X(01)00193-4","article-title":"Transscleral drug delivery for posterior segment disease","volume":"52","author":"Geroski","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.21987_bb0150","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.survophthal.2003.12.009","article-title":"Determinants of eye drop size","volume":"49","author":"Van Santvliet","year":"2004","journal-title":"Surv Ophthalmol"},{"key":"10.1002\/jps.21987_bb0155","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.ajo.2005.08.052","article-title":"Dynamic predictive coding by the retina","volume":"140","author":"Hosoya","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0160","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2004.11.033","article-title":"Dispersion of microemulsion drops in HEMA hydrogel: A potential ophthalmic drug delivery vehicle","volume":"292","author":"Gulsen","year":"2005","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0165","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2005.10.019","article-title":"An in vitro study of the design and development of a novel doughnut\u2010shaped minitablet for intraocular implantation","volume":"310","author":"Choonara","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/pt0804118","article-title":"Studies on a novel doughnut\u2010shaped minitablet for intraocular drug delivery","volume":"8","author":"Choonara","year":"2007","journal-title":"AAPS PharmSciTech"},{"key":"10.1002\/jps.21987_bb0175","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0014-4835(66)80029-5","article-title":"Posterior drainage of the intraocular fluid from the vitreous","volume":"5","author":"Hayreh","year":"1966","journal-title":"Exp Eye Res"},{"key":"10.1002\/jps.21987_bb0180","series-title":"Polymeric site specific pharmacotherapy","first-page":"316","article-title":"Polymeric drug delivery systems for the eye","author":"Weiner","year":"1994"},{"key":"10.1002\/jps.21987_bb0185","first-page":"234","article-title":"Nano and microparticles as controlled drug delivery devices","volume":"3","author":"Kumar","year":"2000","journal-title":"J Pharm Pharmaceut Sci"},{"key":"10.1002\/jps.21987_bb0190","series-title":"Encyclopedia of pharmaceutical technology","first-page":"863","article-title":"Drug delivery\u2010ophthalmic route","author":"Chowhan","year":"2002"},{"key":"10.1002\/jps.21987_bb0195","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1517\/17425247.3.2.275","article-title":"Ocular drug delivery","volume":"3","author":"Ghate","year":"2006","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1002\/jps.21987_bb0200","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1517\/14712598.3.1.45","article-title":"Drug delivery to the retina: Challenges and opportunities","volume":"3","author":"Duvvuri","year":"2003","journal-title":"Expert Opin Biol Ther"},{"key":"10.1002\/jps.21987_bb0205","first-page":"195","article-title":"Novel approaches to ocular drug delivery","volume":"6","author":"Davis","year":"2004","journal-title":"Curr Opin Mol Therap"},{"key":"10.1002\/jps.21987_bb0210","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.addr.2005.07.005","article-title":"The use of mucoadhesive polymers in ocular drug delivery","volume":"57","author":"Ludwig","year":"2005","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.21987_bb0215","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.addr.2005.09.004","article-title":"Topical and systemic drug delivery to the posterior segments","volume":"57","author":"Hughes","year":"2005","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.21987_bb0220","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.addr.2005.09.007","article-title":"Ocular delivery using poly(orto esters)","volume":"57","author":"Heller","year":"2005","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.21987_bb0225","series-title":"Advances in polymer science","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/3-540-45734-8_3","article-title":"Degradable polymer microspheres for controlled drug delivery","author":"Edlund","year":"2002"},{"key":"10.1002\/jps.21987_bb0230","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/S0142-9612(00)00237-4","article-title":"Ocular biomaterials and implants","volume":"22","author":"Lloyd","year":"2001","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0235","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.biomaterials.2006.11.028","article-title":"Ocular drug delivery by liposome\u2010chitosan nanoparticle complexes (LCS\u2010NP)","volume":"28","author":"Diebol","year":"2007","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0240","first-page":"1785","article-title":"Microspheres of biodegradable polymers as a drug delivery system in the vitreous","volume":"32","author":"Moritera","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0245","first-page":"665","article-title":"Ganciclovir\u2010loaded polymer microspheres in rabbit eyes inoculated with human cytomegalovirus","volume":"38","author":"Veloso","year":"1997","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0250","first-page":"1186","article-title":"Transcleral delivery of bioactive protein to the choroid and retina","volume":"41","author":"Ambati","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0255","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bjo.77.4.233","article-title":"Occlusion of retinal vessels using targeted delivery of a platelet aggregating agent","volume":"77","author":"Ogura","year":"1993","journal-title":"Br J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0260","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1001\/archopht.1992.01080140044023","article-title":"Sustained\u2010release ganciclovir therapy for treatment of cytomegalovirus retinitis","volume":"110","author":"Sanborn","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0265","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.21987_bb0270","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained\u2010release ganciclovir implant: A randomized controlled clinical trial","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0275","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.ophtha.2005.10.061","article-title":"Short\u2010term course of intraocular pressure after intravitreal injection of triamcinolone acetonide","volume":"113","author":"Benz","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1002\/jps.21987_bb0280","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.116.1.69","article-title":"An intravitreal sustained\u2010release triamcinolone and 5\u2010fluorouracil co\u2010drug in the treatment of experimental proliferative vitreoretinopathy","volume":"116","author":"Yang","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0285","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bjo.78.9.677","article-title":"Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS","volume":"78","author":"Akula","year":"1994","journal-title":"Br J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0290","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/archopht.1992.01080140111037","article-title":"Intravitreal sustained\u2010release ganciclovir","volume":"110","author":"Smith","year":"1992","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0295","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/archopht.1989.01070020849025","article-title":"Long\u2010term intravitreal ganciclovir therapy for cytomegalovirus retinopathy","volume":"107","author":"Heinemann","year":"1989","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0300","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.ajo.2008.12.034","article-title":"Anatomic and visual outcomes of noninfectious endophthalmitis after intravitreal triamcinolone","volume":"147","author":"Yoon","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0305","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1023\/A:1026464124412","article-title":"Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process","volume":"17","author":"Herroro\u2010Vanrell","year":"2000","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21987_bb0310","first-page":"515","article-title":"Treatment or prevention of herpes simplex virus retinitis with intravitreally injectable crystalline 1\u2010o\u2010hexadecylpropanediol\u20103\u2010phopho\u2010ganciclovir","volume":"43","author":"Cheng","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0315","first-page":"1523","article-title":"Intravitreal toxicology and duration of efficacy of a novel antiviral lipid prodrug of ganciclovir in liposome formulation","volume":"41","author":"Cheng","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0320","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0142-9612(01)00284-8","article-title":"Ocular disposition and tolerance of ganciclovir\u2010loaded albumin nanoparticles after intravitreal injection in rats","volume":"23","author":"Merodio","year":"2002","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0325","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1016\/j.addr.2005.09.005","article-title":"Intraocular sustained drug delivery using implantable polymeric devices","volume":"57","author":"Yasukawa","year":"2005","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.21987_bb0330","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.ejpb.2003.12.002","article-title":"Carrageenan\u2010gelatin mucoadhesive systems for ion\u2010exchange based ophthalmic delivery: In vitro and preliminary in vivo studies","volume":"57","author":"Bonferoni","year":"2004","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21987_bb0335","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ijpharm.2007.03.011","article-title":"Pharmaceutical nanotechnology nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs","volume":"340","author":"Kassem","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0340","first-page":"513","article-title":"Chitosan\u2010sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimization and in vitro characterization","volume":"68","author":"Motwani","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21987_bb0345","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1350-9462(97)00002-5","article-title":"Ophthalmic drug delivery systems\u2010recent advances","volume":"17","author":"Le Bourlais","year":"1998","journal-title":"Prog Retinal Eye Res"},{"key":"10.1002\/jps.21987_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijpharm.2003.12.006","article-title":"Optimization of acyclovir poly(D,L\u2010lactide\u2010co\u2010glycolide) microspheres for intravitreal administration using a factorial design study","volume":"273","author":"Martinez\u2010Sancho","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0355","first-page":"2815","article-title":"A new vitreal drug delivery system using an implantable biodegradable polymeric device","volume":"35","author":"Kimura","year":"1994","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0360","first-page":"3436","article-title":"Injectable microspheres with controlled drug release for glaucoma filtering surgery","volume":"33","author":"Kimura","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0365","first-page":"3125","article-title":"Biodegradable microspheres containing adriamycin in the treatment of proliferative vitreoretinopathy","volume":"33","author":"Moritera","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0370","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0142-9612(01)00291-5","article-title":"Dexamethasone\/PLGA microspheres for continuous delivery of an anti\u2010inflammatory drug for implantable medical devices","volume":"23","author":"Hickey","year":"2002","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0375","unstructured":"Ashton P.2000.Sustained\u2010release inserts help deliver intraocular drugs. (Brief article) (Column) Ophthalmol Times, May."},{"key":"10.1002\/jps.21987_bb0380","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/jop.1992.8.343","article-title":"Intravitreal ganciclovir pharmacokinetics in rabbits and man","volume":"8","author":"Ashton","year":"1992","journal-title":"J Ocular Pharmacol"},{"key":"10.1002\/jps.21987_bb0385","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/156720106776359186","article-title":"Review of ocular drug delivery","volume":"3","author":"Sultana","year":"2006","journal-title":"Curr Drug Deliv"},{"key":"10.1002\/jps.21987_bb0390","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(01)00200-9","article-title":"Biodegradable microspheres for vitreoretinal drug delivery","volume":"52","author":"Herrero\u2010Vanrell","year":"2001","journal-title":"Adv Drug Del Rev"},{"key":"10.1002\/jps.21987_bb0395","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3109\/03639049109026629","article-title":"Implantable controlled release drug delivery systems: A review","volume":"17","author":"Danckwerts","year":"1991","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1002\/jps.21987_bb0400","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1056\/NEJM199707103370203","article-title":"Treatment of cytomegalovirus retinitis with a sustained\u2010release ganciclovir implant","volume":"337","author":"Musch","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1002\/jps.21987_bb0405","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00006534-198205000-00016","article-title":"Capsular contracture around silicone implants: The role of intraluminal antibiotics","volume":"69","author":"Zaheer","year":"1982","journal-title":"Plast Recon Surg"},{"key":"10.1002\/jps.21987_bb0410","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1023\/A:1016012520276","article-title":"Biocompatibility issues of implantable drug delivery systems","volume":"13","author":"Park","year":"1996","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21987_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-5173(80)90094-0","article-title":"Biodegradable drug delivery systems","volume":"7","author":"Wood","year":"1980","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0420","series-title":"Biodegradable polymers as drug delivery systems","first-page":"1","article-title":"Controlled release of bioactive agents from lactide\/glycolide polymers","author":"Lewis","year":"1990"},{"key":"10.1002\/jps.21987_bb0425","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pi.4980100409","article-title":"Polymeric inserts and implants for the controlled release of drugs","volume":"10","author":"Graham","year":"1978","journal-title":"Br Polym J"},{"key":"10.1002\/jps.21987_bb0430","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1056-8719(98)00027-6","article-title":"Therapeutic applications of implantable drug delivery systems","volume":"40","author":"Dash","year":"1998","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1002\/jps.21987_bb0435","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejpb.2004.08.011","article-title":"Studies on a new device for drug delivery to the eye","volume":"59","author":"Pijls","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1002\/jps.21987_bb0440","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijpharm.2007.04.007","article-title":"Capacity and tolerance of a new device for ocular drug delivery","volume":"341","author":"Pijls","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0445","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0002-9394(14)74449-6","article-title":"Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of ulcerative keratitis","volume":"115","author":"Parks","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0450","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/BF02708260","article-title":"Ciprofloxacin@SiO2: Fluorescein nanobubbles","volume":"115","author":"Rosemary","year":"2003","journal-title":"Proc Indian Acad Sci (Chem Sci)"},{"key":"10.1002\/jps.21987_bb0455","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.icl.0000249595.27520.2e","article-title":"Fungal keratitis: Emerging trends and treatment outcomes","volume":"32","author":"Iyer","year":"2006","journal-title":"Eye Contact Lens"},{"key":"10.1002\/jps.21987_bb0460","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1016\/j.jconrel.2006.09.043","article-title":"In vivo tolerance and kinetics of a novel ocular drug delivery device","volume":"116","author":"Pijls","year":"2006","journal-title":"J Control Rel"},{"key":"10.1002\/jps.21987_bb0465","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jconrel.2007.09.006","article-title":"Zero\u2010order therapeutic release from imprinted hydrogel contact lenses within in vitro physiological ocular tear flow","volume":"124","author":"Ali","year":"2007","journal-title":"J Control Rel"},{"key":"10.1002\/jps.21987_bb0470","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0165-2427(00)00219-1","article-title":"Effect of an intravitreal cyclosporine implant on experimental uveitis in horses","volume":"76","author":"Gilger","year":"2000","journal-title":"Vet Immunol Immunopathol"},{"key":"10.1002\/jps.21987_bb0475","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0161-6420(98)91176-9","article-title":"Intravitreal sustained\u2010release cyclosporine in the treatment of experimental uveitis","volume":"105","author":"Jaffe","year":"1998","journal-title":"Ophthalmology"},{"key":"10.1002\/jps.21987_bb0480","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0378-5173(99)00156-8","article-title":"Effect of formulation on the systemic absorption of insulin from enhancer\u2010free ocular devices","volume":"185","author":"Lee","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0485","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1021\/js960423s","article-title":"Effect of Brij\u201078 on systemic delivery of insulin from an ocular device","volume":"86","author":"Lee","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0490","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1021\/js970191c","article-title":"Systemic delivery of insulin via an enhancer\u2010free ocular device","volume":"86","author":"Lee","year":"1997","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0495","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0022-3565(25)23247-5","article-title":"The ocular route for systemic insulin delivery in the albino rabbit","volume":"249","author":"Yamamoto","year":"1989","journal-title":"J Pharm Exp Ther"},{"key":"10.1002\/jps.21987_bb0500","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jps.2600781007","article-title":"Improvement of systemic absorption of insulin through eyes with absorption enhancers","volume":"78","author":"Chiou","year":"1989","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0505","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/jop.1990.6.233","article-title":"Adjustment of blood sugar levels with insulin and glucogon eyedrops in normal and diabetic rabbits","volume":"3","author":"Chiou","year":"1990","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0510","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1146\/annurev.pa.31.040191.002325","article-title":"Systemic delivery of polypeptide drugs through ocular route","volume":"31","author":"Chiou","year":"1991","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1002\/jps.21987_bb0515","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1089\/jop.1993.9.85","article-title":"Chronic systemic delivery of insulin through the ocular route","volume":"9","author":"Hopper","year":"1993","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0520","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/jop.1994.10.101","article-title":"Toxicity of insulin administration chronically to human eye in vivo","volume":"10","author":"Bartlett","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0525","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/jop.1994.10.683","article-title":"Insulin administration to the eyes of normoglycemic human volunteers","volume":"10","author":"Bartlett","year":"1994","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0530","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/j.2042-7158.1994.tb05705.x","article-title":"Effect of preservatives on systemic delivery of insulin by ocular instillation in rabbits","volume":"46","author":"Sasaki","year":"1994","journal-title":"J Pharm Pharmacol"},{"key":"10.1002\/jps.21987_bb0535","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1248\/bpb.18.169","article-title":"Effect of ophthalmic preservatives on serum concentration and local irritation of ocularly applied insulin","volume":"18","author":"Sasaki","year":"1995","journal-title":"Biol Pharm Bull"},{"key":"10.1002\/jps.21987_bb0540","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/jps.2600841104","article-title":"DS\u20101, a modified quillaja saponin, enhances ocular and nasal absorption of insulin","volume":"84","author":"Pillion","year":"1995","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0545","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1089\/jop.1995.11.565","article-title":"Delivery of systemic regular insulin via the ocular route in cats","volume":"11","author":"Morgan","year":"1995","journal-title":"J Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0550","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1021\/js960176s","article-title":"Ocular device for the controlled systemic delivery of insulin","volume":"85","author":"Simamora","year":"1996","journal-title":"J Pharm Sci"},{"key":"10.1002\/jps.21987_bb0555","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1089\/jop.1996.12.515","article-title":"Delivery of systemic regular insulin via the ocular route in dogs","volume":"12","author":"Morgan","year":"1996","journal-title":"Ocul Pharmacol"},{"key":"10.1002\/jps.21987_bb0560","unstructured":"Negvesky GJ,Butrus SI,Farah A,Lee YC,Yalkowsky SH.1999.Gelfoam disc ocular inserts for pupillary dilation in human eyes. The Association for Research in Vision and Ophthalmology (ARVO), Annual Meeting, Fort Lauderdale, FL, pp.S.85. Abstract 53042."},{"key":"10.1002\/jps.21987_bb0565","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0378-5173(98)00418-9","article-title":"Ocular devices for the controlled systemic delivery of insulin: In vitro and in vivo dissolution","volume":"181","author":"Lee","year":"1999","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0570","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0002-9394(98)00443-7","article-title":"Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis","volume":"127","author":"Lim","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0575","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(00)00466-8","article-title":"Fluocinolone acetonide sustained drug delivery device to treat severe uveitis","volume":"107","author":"Jaffe","year":"2000","journal-title":"Ophthalmology"},{"key":"10.1002\/jps.21987_bb0580","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00006982-200004000-00015","article-title":"Dexamethasone sustained drug delivery implant for the treatment of severe uveitis","volume":"20","author":"Jaffe","year":"2000","journal-title":"Retina"},{"key":"10.1002\/jps.21987_bb0585","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archopht.116.1.69","article-title":"An intravitreal sustained\u2010release triamcinolone and 5\u2010fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy","volume":"116","author":"Yang","year":"1998","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0590","unstructured":"Kuppermann BD.2006.Implant delivery of corticosteroids and other pharmacologic agents. Presented at Retina 2006: Emerging New Concepts. Held in conjunction with the American Academy of Ophthalmology 2006 Annual Meeting, November 10\u201311, 2006, Las Vegas."},{"key":"10.1002\/jps.21987_bb0595","unstructured":"Li PY,Shih J,Lo R,Adams B,Agrawal R,Saati S,Humayun MS,Tai YC,Meng E.2007.An electrochemical intraocular drug delivery device, In: Proceedings of the 20th IEEE International Conference on Micro Electro Mechanical Systems, Kobe, Japan, 21\u201325 January, 2007, pp.15\u201318."},{"key":"10.1002\/jps.21987_bb0600","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/BF00578085","article-title":"Coplanar interdigitated band electrodes for electrosynthesis. Part 2. Methoxylation of furan","volume":"24","author":"Belmont","year":"1994","journal-title":"J Appl Electrochem"},{"key":"10.1002\/jps.21987_bb0605","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0169-409X(01)00192-2","article-title":"Biodegradable scleral plugs for vitreoretinal drug delivery","volume":"52","author":"Yasukawa","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1002\/jps.21987_bb0610","unstructured":"Ogura Y,Ikada Y.1998. Biodegradable scleral plug. US Patent5,707,643."},{"key":"10.1002\/jps.21987_bb0615","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0168-3659(95)00074-I","article-title":"Controlled intraocular delivery of ganciclovir with use of biodegradable scleral implant in rabbits","volume":"37","author":"Kunou","year":"1995","journal-title":"J Control Rel"},{"key":"10.1002\/jps.21987_bb0620","unstructured":"Weiner AL,Sinnett K,Johnson S.1995. Tack for intraocular drug delivery and method for inserting and removing the same. US Patent5,466,233."},{"key":"10.1002\/jps.21987_bb0625","unstructured":"Varner SE,de Juan E, Jr.,Shelley T,Barnes AC,Humayun M.2004. Devices for intraocular drug delivery. US Patent6,719,750."},{"key":"10.1002\/jps.21987_bb0630","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0142-9612(97)00243-3","article-title":"Physico\u2010chemical characterization, preparation and performance of poly(methylidene malonate 2.12) nanoparticles","volume":"19","author":"Breton","year":"1998","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0635","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1016\/j.biomaterials.2003.11.021","article-title":"Bioadhesive characterization of poly(methylidene malonate 2.12) microparticles on model extracellular matrix","volume":"25","author":"Chan","year":"2004","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0640","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0378-5173(96)04842-9","article-title":"On shelf stability of freeze\u2010dried poly(methylidene malonate 2.12) nanoparticles","volume":"148","author":"Roy","year":"1997","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0645","series-title":"Targeting of Drugs, 4","first-page":"161","article-title":"New poly (methylidene malonate 2.1.2) nanoparticles: Recent developments","author":"Breton","year":"1994"},{"key":"10.1002\/jps.21987_bb0650","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1023\/A:1018986226557","article-title":"Preparation and characterization of novel poly(methylidene malonate 2.12)\u2010made nanoparticles","volume":"11","author":"Lescure","year":"1994","journal-title":"Pharm Res"},{"key":"10.1002\/jps.21987_bb0655","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijpharm.2006.05.053","article-title":"Biodegradable scleral implants as new triamcinolone acetonide delivery systems","volume":"322","author":"Felt\u2010Baeyens","year":"2006","journal-title":"Int J Pharm"},{"key":"10.1002\/jps.21987_bb0660","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1167\/iovs.02-0956","article-title":"Intraocular tissue distribution of betamethasone after intrascleral administration using a non\u2010biodegradable sustained drug delivery device","volume":"44","author":"Okabe","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0665","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/archopht.1979.01020020087021","article-title":"Experimental endophthalmitis treated with an implantable osmotic minipump","volume":"97","author":"Michelson","year":"1979","journal-title":"Arch Ophthalmol"},{"key":"10.1002\/jps.21987_bb0670","first-page":"102","article-title":"An ocular perfusion system","volume":"19","author":"Eliason","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0675","first-page":"140","article-title":"A method for chronic drug infusion into the eye","volume":"28","author":"Miki","year":"1984","journal-title":"Jpn J Ophthalmol"},{"key":"10.1002\/jps.21987_bb0680","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0142-9612(00)00169-1","article-title":"Biocompatibility and biodegradation of intravitreal hyaluronan implants in rabbits","volume":"22","author":"Avitabile","year":"2001","journal-title":"Biomaterials"},{"key":"10.1002\/jps.21987_bb0685","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1167\/iovs.03-0821","article-title":"Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis","volume":"45","author":"Li","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1002\/jps.21987_bb0690","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/jop.2007.0097","article-title":"Methylprednisolone delivery to the back of the eye using hydrogel iontophoresis","volume":"24","author":"Eljarrat\u2010Binstock","year":"2008","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1002\/jps.21987_bb0695","first-page":"32","article-title":"New developments In the transscleral delivery of ophthalmic agents. The profile of the drug being delivered is as important as the delivery method","author":"Csaky","year":"2007","journal-title":"Retina Today"},{"key":"10.1002\/jps.21987_bb0700","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1136\/bjo.83.11.1225","article-title":"New developments in sustained release drug delivery for the treatment of intraocular disease","volume":"83","author":"Velez","year":"1999","journal-title":"Br J Ophthalmol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915326320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354915326320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T03:06:13Z","timestamp":1739415973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354915326320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5]]},"references-count":139,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,5]]}},"alternative-id":["S0022354915326320"],"URL":"https:\/\/doi.org\/10.1002\/jps.21987","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2010,5]]}}}